Respiratory Care Devices Market Size and Forecast 2025–2033

The global respiratory care devices market is poised for sustained expansion over the next decade. The market is projected to grow from US$ 24.16 billion in 2024 to approximately US$ 49.19 billion by 2033, registering a compound annual growth rate (CAGR) of 8.22% between 2025 and 2033.

The primary drivers behind this growth include the rising prevalence of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and sleep apnea. Increasing air pollution levels, aging populations, higher smoking rates in certain regions, and post-pandemic awareness of respiratory health are further accelerating demand for advanced respiratory devices worldwide.

Respiratory Care Devices Market Overview

Respiratory care devices are medical technologies designed to assist patients experiencing breathing difficulties or chronic respiratory disorders. These devices are used in hospitals, clinics, emergency care settings, and increasingly in home healthcare environments.

Key respiratory care devices include:

·        Nebulizers – Convert liquid medication into mist for inhalation.

·        Inhalers – Deliver precise medication doses directly to the lungs.

·        CPAP (Continuous Positive Airway Pressure) machines – Used primarily for sleep apnea treatment.

·        Ventilators – Provide mechanical breathing support for critically ill patients.

·        Oxygen concentrators – Deliver supplemental oxygen to patients with chronic respiratory diseases.

Beyond treatment, these devices also support monitoring, therapy optimization, and quality-of-life improvements for patients with chronic conditions. The growing shift toward home-based healthcare and portable respiratory solutions is reshaping competitive strategies across the industry.

Download Free Sample Report:https://www.renub.com/request-sample-page.php?gturl=respiratory-care-devices-market-competitor-analysis-p.php

Top Companies in the Respiratory Care Devices Industry

Medtronic Plc

Established: 1949
Headquarters: Ireland
Revenue: US$ 32.4 Billion (2023)

Medtronic is a global leader in medical technology, offering a broad portfolio that includes respiratory monitoring and ventilation solutions. The company serves hospitals, clinics, and healthcare providers worldwide across Asia, Europe, the Americas, the Middle East, and Africa. Its strong R&D capabilities and diversified product portfolio give it a competitive advantage in high-acuity respiratory care.

Koninklijke Philips

Established: 1891
Headquarters: Netherlands

Philips is a major health technology company with significant operations in respiratory care. Its offerings include CPAP devices, ventilators, and homecare respiratory systems. The company integrates precision diagnostics and monitoring with respiratory support technologies, enabling connected care models and remote patient monitoring.

General Electric Company

Established: 1892
Headquarters: United States

General Electric (GE), through its healthcare division, provides advanced medical imaging and diagnostic systems. While historically diversified across aviation, power, and renewable energy, GE Healthcare supports respiratory management through monitoring and critical care solutions integrated into hospital systems.

Masimo Corporation

Established: 1989
Headquarters: United States

Masimo specializes in non-invasive monitoring technologies, including pulse oximetry systems essential in respiratory care. Its advanced monitoring capabilities enhance oxygen saturation tracking and patient safety across hospital and homecare settings.

ResMed Inc.

Established: 1989
Headquarters: United States

ResMed is a dominant player in sleep apnea and COPD management. Its portfolio includes CPAP, APAP, VPAP, and cloud-connected respiratory devices. The company’s SaaS-based digital health platforms strengthen remote care capabilities and improve therapy adherence.

Becton Dickinson

Established: 1897
Headquarters: United States

BD develops infusion systems, monitoring equipment, and respiratory-related devices. Its strong global manufacturing presence supports supply chain resilience and broad customer reach across hospitals and research laboratories.

Inogen Inc.

Established: 2001
Headquarters: United States

Inogen specializes in portable oxygen concentrators (POCs). Its lightweight, battery-powered solutions enhance patient mobility compared to traditional oxygen therapy systems. In 2023, Inogen completed the acquisition of Physio-Assist SAS to expand its respiratory product portfolio.

Sustainability and Strategic Developments

Baxter International Inc.

Baxter has significantly strengthened its sustainability initiatives. In 2024, the company reduced Scope 1 and 2 greenhouse gas emissions by 13.5% compared to 2023 and 18.8% relative to its 2020 baseline. Baxter aims to reduce emissions by 25% by 2030 and achieve carbon neutrality in direct operations by 2040.

The company invested approximately US$ 12 million in 175 energy efficiency projects, including solar installations and biomass-fueled steam generators.

Invacare Corporation

Invacare aims to achieve net-zero emissions by 2045. Invacare EMEA has obtained ISO 14001:2015 Environmental Management System certification, reinforcing its commitment to environmental sustainability.

In September 2025, Invacare participated in the 83rd FIP World Congress of Pharmacy and Pharmaceutical Sciences in Copenhagen, highlighting its engagement with frontline healthcare communities.

Vyaire Medical Inc.

In October 2024, ZOLL (an Asahi Kasei affiliate) acquired ventilator product lines including bellavista®, fabian®, LTV®, and 3100 HFOV from Vyaire Medical, strengthening its respiratory product portfolio.

ICU Medical Inc.

In May 2025, ICU Medical collaborated with VisionHealth GmbH to launch MyAcapella, a mobile application designed to enhance OPEP therapy for chronic respiratory disease patients. The app improves adherence tracking and patient engagement.

Getinge AB

Getinge continues expansion through acquisitions. In 2024, it acquired Paragonix Technologies for approximately USD 477 million and previously acquired Healthmark Industries for USD 320 million, strengthening its sterile reprocessing and healthcare capabilities.

SWOT Highlights of Key Players

OMRON Healthcare Inc.

Strengths:

·        Strong brand recognition in nebulizers and respiratory equipment

·        Extensive R&D investments

·        Reliable, user-friendly device design

·        Established global distribution network

Omron’s focus on portable, energy-efficient, and home-use devices aligns with aging demographics and chronic disease prevalence.

Bio-Med Devices

Strengths:

·        High-performance ventilators for neonatal, pediatric, and adult care

·        Strong regulatory compliance (FDA and ISO standards)

·        Close collaboration with respiratory therapists

·        Established U.S. hospital presence

The company is well-positioned to meet growing demand for wearable and transportable respiratory solutions.

Competitive Market Structure

The respiratory care devices market is characterized by:

·        Continuous product innovation

·        Increasing digital integration

·        Strategic mergers and acquisitions

·        Sustainability commitments

·        Expansion into emerging markets

Major players competing globally include:

·        Masimo Corporation

·        Fisher & Paykel Healthcare Corporation

·        Drägerwerk AG & Co. KGaA

·        Vyaire Medical Inc.

·        Baxter International Inc.

·        ICU Medical Inc.

·        Beijing Aeonmed Co. Ltd.

·        Smiths Medical PLC

·        Invacare Corporation

·        Flexicare Medical Limited

·        OMRON Healthcare Inc.

·        Bio-Med Devices

·        Medtronic Plc

·        Koninklijke Philips

·        GE Healthcare

·        ResMed Inc.

·        Becton Dickinson

·        Turn Medical

·        Getinge AB

·        Inogen Inc.

Each company analysis typically includes:

·        Company Overview and History

·        Business Model and Workforce Structure

·        Executive Leadership and Board Composition

·        Mergers, Acquisitions, and Partnerships

·        Sustainability Initiatives

·        Product Portfolio and Pipeline

·        Quality Standards and Benchmarking

·        SWOT Analysis

·        Revenue Analysis

Final Thoughts

The respiratory care devices market is entering a decade of strong growth and technological transformation. With the market expected to nearly double from US$ 24.16 billion in 2024 to US$ 49.19 billion by 2033, companies are investing heavily in innovation, digital health integration, sustainability, and homecare expansion.

Rising global cases of asthma, COPD, and sleep apnea—combined with aging populations and increased awareness of respiratory health—will continue to fuel demand. Competitive differentiation will increasingly depend on portable device design, remote monitoring capabilities, regulatory compliance, and environmental responsibility.

As respiratory care transitions from hospital-centric treatment to connected, patient-centered ecosystems, industry leaders that combine